SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is experiencing a surge in trading volume and investor interest driven by unconfirmed market rumors regarding a potential acquisition by a large-cap biopharmaceutical company. The community remains divided, with long-term holders eyeing a potential buyout premium while others caution that the lack of official confirmation from the company or major outlets suggests the price action may be speculative volatility.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as investors react to its recent NYSE debut and the significant premium currently trading above its net asset value. The community is actively debating the impact of a six-month share lockup on the float, with many speculating on the fund's potential for future volatility driven by its exposure to high-profile private AI companies like Anthropic, SpaceX, and OpenAI.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as a highly speculative meme coin, drawing intense division between traders gambling on its volatility and those warning of a potential pump-and-dump scheme. The community remains polarized, with some observing chart patterns and accumulation while others caution that the asset lacks utility and exhibits significant concentration among top holders.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing heightened volatility and selling pressure following a post-earnings sell-off, leading the community to intensely debate whether the decline is driven by technical gap-filling, broader market weakness, or concerns regarding management's long-term strategy and PepsiCo's influence. Investors are actively discussing the stock's valuation and the potential for a recovery, with many closely monitoring technical support levels while expressing frustration over the discrepancy between strong financial performance and the recent price action.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is generating significant buzz as investors weigh upcoming earnings reports against expectations for a major NASA Lunar Terrain Vehicle (LTV) contract award. The community remains deeply divided, with bulls pointing to strong forward revenue guidance and long-term space infrastructure growth, while bears emphasize execution risks and the volatility associated with contract timing.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly Inc. is experiencing intense volatility and community debate as traders grapple with a sharp post-earnings rally, heavy insider selling, and high short interest. While bulls highlight potential for long-term growth driven by AI and edge computing, bears argue the valuation is detached from fundamentals, leading to frequent clashes over technical resistance levels and short-squeeze potential.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

4CHAN is trending as the community positions the token as the 'bitcoin of memecoins,' emphasizing its origins and the 'meme magick' driving its decentralized, exchange-free ecosystem. Investors are actively discussing the potential of its high supply of zeros, framing the current market fluctuations as a strategic buying opportunity for long-term holders aiming for generational gains.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently trending as investors react to a new shelf registration filing, sparking debate about potential financial stress versus strategic capital management. The community remains deeply divided, with some traders actively betting on a bullish breakout toward key resistance levels, while others highlight concerns over regulatory pressures, margin compression, and persistent downward price action.

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

Estee Lauder Cos., Inc. - Ordinary Shares - Class A

Estee Lauder Cos. Inc

Estee Lauder is trending as investors weigh a potential business combination with Spanish beauty group Puig, a strategic move aimed at achieving greater global scale despite current market headwinds. While some community members view the consolidation as a necessary step to overcome recent performance struggles, others remain cautious due to concerns over potential equity dilution and the company's existing debt profile.

Apollo Global Management, Inc. provides asset management services. It offers its clients excess return at every point along the risk-reward spectrum from investment grade to private equity with a focus on three business strategies: yield, hybrid, and equity. It operates through following segments: Asset Management, Retirement Services and Principal Investing. The Asset Management segment focuses on credit and equity investing strategies. The Retirement Services and Principal Investing segment consists of realized performance fee income, realized investment income from balance sheet investments, and certain allocable expenses related to corporate functions supporting the entire company. The company was founded by Marc Rowan in 1990 and is headquartered in New York, NY.

Apollo Global Management Inc

Apollo Global Management is currently the subject of intense investor discussion as it balances strong asset growth with sector-wide anxiety regarding private credit liquidity. While the company is actively expanding its digital infrastructure and sports investment footprint, market participants remain closely divided between those viewing the stock as a resilient value opportunity and others concerned about the potential for broader credit market contagion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biotech stocks remain a hot sector for retail traders on Stocktwits,&nbsp;which collectively boast over 3.45 million followers.&nbsp;In January, several biotech names saw explosive gains as investors bet on breakthrough treatments, key partnerships, and regulatory milestones.According to Stocktwits data, these five biotech stocks saw the highest surge in retail following this month.CARGO Therapeutics Inc. (CRGX) – 445% Jump In FollowersCARGO Therapeutics, a clinical-stage biotech company focused on cancer treatments, saw its stock collapse even as retail interest surged.&nbsp;In January, the FDA cleared its Investigational New Drug (IND) application for CRG-023, a novel tri-specific CAR T therapy designed to tackle relapse factors in B-cell malignancies.&nbsp;However, the company later announced it would discontinue a Phase II trial of its lead candidate, firi-cel, after an ad hoc safety analysis revealed an unfavorable benefit-risk profile.&nbsp;Wall Street analysts issued downgrades, and CARGO’s stock is on track to plunge more than 76% in January — its worst month since going public in November 2023.&nbsp;Short interest stands at 15.1%, according to Koyfin data.Sana Biotechnology Inc. (SANA) – 185% Jump In FollowersSana Biotechnology, which focuses on engineered cell therapies, captured investor attention with a potential&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sana-biotech-stock-triples-after-type-1-diabetes-trial-data/chGBWsVRZO">breakthrough</a> in type 1 diabetes.&nbsp;The company demonstrated earlier this month that its hypoimmune edits allowed islet cell transplant survival without immunosuppression.&nbsp;Analysts praised the findings, driving the stock up roughly 114% in January — its best month since its March 2021 market debut.&nbsp;Short interest is at 16.6%.Silexion Therapeutics Corp. (SLXN) – 92% Jump In FollowersSilexion, an oncology-focused biotech developing RNA interference therapies, gained momentum after releasing preclinical data on a second-generation siRNA candidate, SIL-204.&nbsp;The treatment&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/slxn-stock-hits-record-low-after-pricing-5m-offering/chGtwKoRng">showed</a> synergistic efficacy when combined with first-line chemotherapy for pancreatic cancer.&nbsp;Although the stock gained just 2% in January, it marked its best month since November.&nbsp;Short interest remains low at 2.4%.AEON Biopharma Inc. (AEON) – 81% Jump In FollowersAEON Biopharma is developing ABP-450, a botulinum toxin complex similar to Evolus’ Jeuveau, for medical indications such as chronic migraine.&nbsp;Retail traders appeared to buy the dip after AEON priced a $20 million public offering earlier this month, which initially sent shares tumbling.&nbsp;The stock is headed for a 77% drop in January, its worst month since going public via a SPAC merger in July 2023.&nbsp;Short interest is just 0.2%, according to Koyfin.Kairos Pharma (KAPA) – 78% Jump In FollowersKairos Pharma, a clinical-stage biopharmaceutical company, saw retail interest soar this month after breaking key resistance levels and securing crucial investments.&nbsp;The company is testing its lead candidate, ENV105 — which targets a protein linked to resistance in cancer treatments — in Phase 2 trials for castrate-resistant prostate cancer and Phase 1 trials for lung cancer.The stock gained momentum following CEO John Yu’s positive comments at an investor healthcare summit this month and the completion of a $3.5 million PIPE transaction.&nbsp;Kairos shares are set to decline 2.6% in January, marking their worst month since October.&nbsp;Short interest remains&nbsp;negligible at 0.1%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hand holding test tube over stock data on computer monitor. | Image source: Getty Images

Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why

Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts.

Equity

Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts.


The biotech sector remains a hotbed for retail investor interest, with over 3.4 million users following these stocks on Stocktwits. Last week, the below three companies saw the highest increases in retail following:Kairos Pharma Ltd. (+83%)Kairos Pharma, a clinical-stage biopharmaceutical company focused on cancer therapeutics, saw the most spike in retail chatter.&nbsp;The company is testing its lead candidate, ENV105 — which targets a protein linked to resistance in cancer treatments — in Phase 2 trials for castrate-resistant prostate cancer and Phase 1 trials for lung cancer.Retail interest soared last week after Kairos broke key resistance levels and secured crucial investments.&nbsp;The stock surged nearly 120% last Monday following positive comments from CEO John Yu at an investor healthcare summit.&nbsp;Additionally, the company completed a $3.5 million PIPE transaction, which the CEO said would ensure the continued progress of its clinical trials and asset development.&nbsp;Despite these gains, Kairos has lost 21% of its value since its NYSE debut in September.OS Therapies Inc. (+39%)Shares of OS Therapies jumped after the company reported positive clinical trial data for its OST-HER2 candidate, which targets a rare bone cancer that spreads to the lungs.&nbsp;Following the announcement, Maxim analyst Jason McCarthy raised the firm’s price target to $15 from $8, maintaining a ‘Buy’ rating.&nbsp;The data has positioned OS Therapies to meet with the FDA by the end of the first quarter of 2025 to discuss the possibility of filing for accelerated approval.The company is focused on oncology treatments, with OST-HER2 being its lead immunotherapy asset. It leverages listeria bacteria’s immune-stimulatory effects to target the HER2 protein in cancer cells.AEON Biopharma Inc. (+19%)AEON Biopharma is a company developing the proprietary botulinum toxin complex ABP-450, a biosimilar to Evolus’ Jeuveau, approved for cosmetic use, but AEON is developing it for medical indications.&nbsp;The company’s manufacturing partner, Daewoong, produces ABP-450 in FDA-approved facilities under current Good Manufacturing Practices (cGMP).Although there were no specific catalysts driving the recent spike, it appears that retail investors were buying the dip after the company priced a public offering to raise $20 million earlier this month, which had caused the stock to slide.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why

Cancer treatments, FDA breakthroughs, and other developments fueled a sharp spike in interest for these biotech players, as investors bet on promising clinical data and strategic moves.

Cryptocurrencies were on fire last week and therefore it should come as no surprise that Stocktwits users turned their attention increasingly toward the crypto and allied space. Among the 10 stocks that saw the biggest increase in watcher count on Stocktwits, four were cryptocurrencies and two were Bitcoin miners.Here’s a compilation of stocks/cryptos that were closely followed by retail last week along with their watcher count:<ul><li>Dogecoin (<a class="mention" data-mention="$DOGE.X" data-symbol-id="DOGE.X" href="https://stocktwits.com/symbol/DOGE.X" target="_blank">$DOGE.X</a>) (336,178)</li><li>SPDR S&amp;P 500 ETF Trust (<a class="mention" data-mention="$SPY" data-symbol-id="SPY" href="https://stocktwits.com/symbol/SPY" target="_blank">$SPY</a>) (537,941)</li><li>Bitcoin (<a class="mention" data-mention="$BTC.X" data-symbol-id="BTC.X" href="https://stocktwits.com/symbol/BTC.X" target="_blank">$BTC.X</a>) ($601,174)</li><li>Ripple (<a class="mention" data-mention="$XRP.X" data-symbol-id="XRP.X" href="https://stocktwits.com/symbol/XRP.X" target="_blank">$XRP.X</a>) (174,221)</li><li>Innovation Beverage Group Ltd. (<a class="mention" data-mention="$IBG" data-symbol-id="IBG" href="https://stocktwits.com/symbol/IBG" target="_blank">$IBG</a>) (1,260)</li><li>Tesla, Inc. (<a class="mention" data-mention="$TSLA" data-symbol-id="TSLA" href="https://stocktwits.com/symbol/TSLA" target="_blank">$TSLA</a>) (980,127)</li><li>PepeCoin (<a class="mention" data-mention="$PEPE.X" data-symbol-id="PEPE.X" href="https://stocktwits.com/symbol/PEPE.X" target="_blank">$PEPE.X</a>) (17,692)</li><li>Kairos Pharma Ltd. (<a class="mention" data-mention="$KAPA" data-symbol-id="KAPA" href="https://stocktwits.com/symbol/KAPA" target="_blank">$KAPA</a>) (1,076)</li><li>Mara Holdings Ltd. (<a class="mention" data-mention="$MARA" data-symbol-id="MARA" href="https://stocktwits.com/symbol/MARA" target="_blank">$MARA</a>) (147,043)</li><li>BTC Digital Ltd. (<a class="mention" data-mention="$BTCT" data-symbol-id="BTCT" href="https://stocktwits.com/symbol/BTCT" target="_blank">$BTCT</a>) (4,228)</li></ul>Dogecoin:&nbsp;Dogecoin, a meme coin, was on a tear last week as it went past the $0.40 level before pulling back since the mid-week. The retail crowd are factoring in the meme crypto breaking above its May 2021 highs of $0.74.&nbsp;SPY: The SPY, which is an exchange-traded fund that tracks the broader S&amp;P 500 Index, closed at a record high of $598.76 last Monday. The ETF has come under pressure since then amid fears that the Federal Reserve may give rate cuts a pass at the December meeting. As the year draws to the close and the market enters a seasonally strong period, retail interest in the ETF has been on the rise.Bitcoin:&nbsp;Donald Trump’s victory in the Nov. 5 election has set in motion broad-based buying in the crypto space amid hopes his policies would be more crypto-friendly. Bitcoin rose to a record high past the $93K level last week before pulling back to the $90K level. It has started the new week on a firmer note and has rebounded toward the $92K level.Ripple: Blockchain company Ripple’s native coin, the XRP, rallied past the $1 against the U.S. dollar last week amid hopes that SEC Chair Gary Gensler would be replaced. The current SEC Chair has gone after Ripple and the regulator has an ongoing lawsuit against the company for raising&nbsp;more than $1.3 billion in 2013 by selling XRP in an unregistered public offering.&nbsp;Innovation Beverage: Australian beverage maker Innovation Beverage, which sells domestically and in the U.S., saw its Nasdaq-listed shares jump 40% last week. The gains have been accompanied by a surge in volumes traded. Following a recent initial public offering, the stock was listed on Sept. 26.Retailers on the Stocktwits see scope for further upside as some of them pointed to the stock being a subject of interest on WallStreetBets reddit forum.Tesla: Trump’s victory led to a surge in Tesla shares past the $350 mark (on an intraday basis) last week but they have pulled back since then. Tesla investors view Elon Musk’s closeness to Trump as a positive for the stock even as the company’s electric-vehicle business is awaiting an inflection.PepeCoin:&nbsp;PepeCoin, another meme coin that has generated interest among retailers, more than doubled in the seven sessions that ended Nov. 9, coinciding with the presidential election. It topped $5 on Nov. 9 but has retreated since then and traded around the $4 mark.&nbsp;&nbsp;Kairos Pharma: Shares of California-based nano-cap oncology-focused clinical-stage biotech Kairos surged past $2 on Tuesday on above-average volume, with retail frenzy propping up the stock.. The buying continued in the next session before moderating. Kairos is a newly public company and was listed in mid-September.&nbsp;Mara Holdings:&nbsp;Bitcoin miner Mara’s shares plunged on Wednesday after the company reported a third-quarter revenue miss. Retail, however, is betting on the company in the hopes that the Bitcoin rally could help the miner stage a comeback.BTC Digital:&nbsp; BTC Digital shares soared over 950% to $19.27 in the week ended Nov. 15, rising from under $2 in the previous week. Retailers on the Stocktwits are bullish on the bitcoin miner.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/10-stocks-with-biggest-message-volume-on-stocktwits/cJ4HwPIRQP">10 Most Active Stocks On Stockwits Last Week With Message Volume Spurt</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

Trump trades have continued to evince retail attention. 

10 Stocks/Cryptos With Biggest Increases In Followers On Stocktwits Last Week

Dogecoin, SPY, Bitcoin, Ripple and Innovation Beverage were among the securities that drew retail attention last week.

Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.

KAPA
Kairos Pharma Ltd.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest KAPA News

KAPAKairos Pharma Ltd.